-
公开(公告)号:US06569883B1
公开(公告)日:2003-05-27
申请号:US09305194
申请日:1999-05-05
申请人: Michael Brian Tyers , Ian Harold Coates , David Cedric Humber , George Blanch Ewan , James Angus Bell
发明人: Michael Brian Tyers , Ian Harold Coates , David Cedric Humber , George Blanch Ewan , James Angus Bell
IPC分类号: A61K31415
CPC分类号: A61K31/4178 , A61K31/415 , Y10S514/966
摘要: The invention relates to the use of compounds of the general formula (I) wherein R1 represents a hydrogen atom or a C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl-(C1-4)alkyl, C3-6 alkenyl, C3-10 alkynyl, phenyl or phenyl-C1-3 alkyl group; and one of the groups represented by R2, R3 and R4 is a hydrogen atom or a C1-6 alkyl, C3-7cycloalkyl, C2-6 alkenyl or phenyl-C1-3 alkyl group and each of the other two groups, which may be the same or different, represents a hydrogen atom or a C1-6 alkyl group; and physiologically acceptable salts and solvates thereof, for the relief of nausea and vomiting and/or the promotion of gastric emptying and for the manufacture of a medicament for this purpose.
摘要翻译: 本发明涉及通式(I)的化合物,其中R 1表示氢原子或C 1-10烷基,C 3-7环烷基,C 3-7环烷基 - (C 1-4)烷基,C 3-6烯基,C 3 -10炔基,苯基或苯基-C 1-3烷基; 由R 2,R 3和R 4表示的基团之一是氢原子或C 1-6烷基,C 3-7环烷基,C 2-6烯基或苯基-C 1-3烷基,其它两个基团可以是 相同或不同,代表氢原子或C1-6烷基;及其生理上可接受的盐和溶剂合物,用于缓解恶心和呕吐和/或促进胃排空和用于制造用于此目的的药物 。
-
公开(公告)号:US5922749A
公开(公告)日:1999-07-13
申请号:US689719
申请日:1996-08-16
申请人: Michael Brian Tyers , Ian Harold Coates , David Cedric Humber , George Blanch Ewan , James Angus Bell
发明人: Michael Brian Tyers , Ian Harold Coates , David Cedric Humber , George Blanch Ewan , James Angus Bell
IPC分类号: A61K31/415 , A61K31/4178
CPC分类号: A61K31/4178 , A61K31/415 , Y10S514/966
摘要: The invention relates to the use of compounds of the general formula (I) ##STR1## wherein R.sup.1 represents a hydrogen atom or a C.sub.1-10 alkyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkyl-(C.sub.1-4) alkyl, C.sub.3-6 alkenyl, C.sub.3-10 alkynyl, phenyl or phenyl-C.sub.1-3 alkyl group; and one of the groups represented byR.sup.2, R.sup.3 and R.sup.4 is a hydrogen atom or a C.sub.1-6 alkyl, C.sub.3-7 cycloalkyl, C.sub.2-6 alkenyl or phenyl-C.sub.1-3 alkyl group and each of the other two groups, which may be the same or different, represents a hydrogen atom or a C.sub.1-6 alkyl group;and physiologically acceptable salts and solvates thereof, for the relief of nausea and vomiting and/or the promotion of gastric emptying and for the manufacture of a medicament for this purpose. Promotion of gastric emptying may be for the relief of gastro-intestinal disorders associated with gastric stasis or may be of advantage in radiological examination procedures.
摘要翻译: 本发明涉及通式(I)的化合物,其中R 1表示氢原子或C 1-10烷基,C 3-7环烷基,C 3-7环烷基 - (C 1-4)烷基,C 3-6烯基, C 3-10炔基,苯基或苯基-C 1-3烷基; 由R 2,R 3和R 4表示的基团之一是氢原子或C 1-6烷基,C 3-7环烷基,C 2-6烯基或苯基-C 1-3烷基以及其它两个基团 相同或不同,表示氢原子或C1-6烷基; 及其生理上可接受的盐和溶剂化物,用于缓解恶心和呕吐和/或促进胃排空和用于制造用于此目的的药物。 促进胃排空可能是为了缓解与胃潴留相关的胃肠道疾病,或者在放射学检查程序中可能是有利的。
-
公开(公告)号:US06544550B1
公开(公告)日:2003-04-08
申请号:US08156727
申请日:1993-11-24
IPC分类号: A61K948
CPC分类号: A61K31/57 , A61K31/415 , A61K2300/00
摘要: The invention relates to the co-administration in human or veterinary medicine of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one or a physiologically acceptable salt or solvate thereof and dexamethasone or a physiologically acceptable salt or ester thereof. The two active ingredients, which may be administered separately either simultaneously or sequentially, or may be combined in a single pharmaceutical preparation, are useful in the relief and/or prevention of nausea and vomiting.
摘要翻译: 本发明涉及人或兽医学中1,2,3,9-四氢-9-甲基-3 - [(2-甲基-1H-咪唑-1-基)甲基] -4H-咔唑的共同给药 -4-酮或其生理学上可接受的盐或溶剂化物,以及地塞米松或其生理上可接受的盐或酯。 可以单独或依次单独施用或可以组合在单一药物制剂中的两种活性成分可用于缓解和/或预防恶心和呕吐。
-
公开(公告)号:US06221878B1
公开(公告)日:2001-04-24
申请号:US08402529
申请日:1995-03-10
申请人: Michael Brian Tyers
发明人: Michael Brian Tyers
IPC分类号: A61K31404
CPC分类号: A61K31/415 , A61K31/445 , A61K31/46 , A61K31/50 , A61K31/55
摘要: The invention relates to the use of compounds which act as antagonists of 5-hydroxytryptamine (5-HT) at 5-HT3 receptors for the treatment of depression.
摘要翻译: 本发明涉及在5-HT 3受体上作为5-羟色胺(5-HT)拮抗剂的化合物用于治疗抑郁症的用途。
-
-
-